Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan

Ichiro Shintaku, Makoto Satoh, Eijiro Okajima, Hiroyuki Fujimoto, Toshiyuki Kamoto, Osamu Ogawa, Koji Kawai, Hideyuki Akaza, Taiji Tsukamoto, Seiji Naito, Tsuneharu Miki, Yoichi Arai

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

Background: As a risk classification system of metastatic germ cell tumors, the International Germ Cell Consensus (IGCC) classification was proposed in 1997 and has received broad approval. Since the IGCC classification was based on patients treated between 1975 and 1990, we aimed to investigate whether survival has improved for more recently treated Japanese patients. Methods: We analyzed 296 patients with metastatic germ cell tumors treated at seven hospitals in Japan between 1990 and 2001. These cases are classified as good, intermediate or poor prognosis groups by the IGCC classification. The 5-year progression-free and the 5-year overall survivals were calculated for each prognosis group. Results: The median follow-up period of all patients was 53 months. In 227 non-seminomatous germ cell tumor cases, the 5-year progression-free survival (95% confidence interval) for good (n = 55), intermediate (n = 106) and poor (n = 66) prognosis was 96%; (91-100), 71% (62-80) and 52% (39-65) (P < 0.001), respectively. The 5-year overall survival was 94% (88-100), 81% (73-89) and 61% (49-73) (P < 0.001), respectively. In 69 seminoma cases, the 5-year progression-free survival for good (n = 64) and intermediate (n = 5) prognosis was 78% (67-89) and 80% (45-100) (P = 0.98), respectively. The 5-year overall survival was 90% (82-99) and 80% (45-100) (P = 0.49), respectively. Conclusions: There was a trend of increase in survival for any risk groups and, in particular, large increase in survival for patients with a poor prognosis. This increase is most likely attributed to more effective chemotherapy regimens and more extensive care in the experienced institutes.

Original languageEnglish
Pages (from-to)281-287
Number of pages7
JournalJapanese journal of clinical oncology
Volume38
Issue number4
DOIs
Publication statusPublished - 2008 Apr

Keywords

  • Chemotherapy
  • Etoposide
  • Germ cell tumor
  • IGCC classification
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan'. Together they form a unique fingerprint.

Cite this